InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
首席执行官已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Browse the full record of transactions filed by Malik Aamir, 董事长兼首席执行官. Officer active across 1 company, notably PFIZER INC. Aggregated, 2 disclosures have been recorded. History available since 31 August 2021. The latest transaction was filed on 31 August 2024 (Retenue fiscale). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Malik Aamir
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报2 总计
20,195 股@ US$29.01100.0% 占其流量Common StockSEC:0001225208-24-008338:0
43,412 股0Common StockSEC:0001225208-21-011947:0
2 条申报中的 2 条
About Malik Aamir
Aamir Malik is the Chief Executive Officer at Pfizer Inc. As CEO, he is responsible for the strategic direction and operations of the company. His experience in the pharmaceutical industry is essential for growth and innovation at Pfizer.
